Chen YY, Yeh CN*, Tseng JH, Chen JS, Chen TW, Tsai CY, Cheng CT, Jan YY, Chen MF.Imatinib mesylate for patients with recurrent or metastatic gastrointestinal stromal tumors expressing kit : A decade experience from Taiwan. Translational oncology. 2011 ; 4:328-325. (SCI; IF=3.393; Oncology 97/184)
Jen-Shi Chen, Yen-Yang Chen, Jen-Sheng Huang, Kun-Yun Yeh, Ping-Tsung Chen, Wen-Chi Shen, Hung-Chih Hsu, Yung-Chung Lin and Hung-Ming Wang. A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer. Gastric cancer. 2012;15:49-55. (SCI; IF=1.897; Gastroenterology & hepatology 44/71)
Yen-Yang Chen, Chun-Nan Yeh*, Chi-Tung Cheng, Tsung-Wen Chen, Kun-Ming Rau, Yi-Yin Jan,Miin-Fu Chen.Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance. World journal of gastroenterology.2011;17:2113-2119. (SCI; IF=1.897; Gastroenterology & hepatology 35/71)
Wu chi ache, Tai-jan chiu, Meng-Chih Lin, Jui-Ling Wang, Kun ming Rau, Chen YY , Huang CH*.Pemetrexed as third-line chemotherapy for locally advanced and metastatic non-small cell lung cancer (NSCLC) : A retrospective analysis.2011;27:157-164
Chen YH, Lu HI, Huang CH, Rau KM, Chiu YC, Wang YM, Chen YY, Liu CT, Li SH*.The use of trimodality treatment of locally advanced resectable esophageal squamous cell carcinoma: a single institute experience in southern Taiwan. Journal of Cancer Research and Practice. 2011; Oct 27(5): 200-210
